Edmon Jennings, Genentech vice president for sales and marketing, faces federal criminal charges involving an alleged bribery and kickback scheme designed to boost Protropin sales. Four other individuals, none employed by Genentech, also were indicted, as was Northbrook, Ill.-based Caremark Inc., a home-health care company that had an exclusive distribution deal for Protropin.